The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors
3 other identifiers
interventional
60
1 country
1
Brief Summary
The purpose of this study is to investigate the effects of long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) on immune function and cardiovascular disease risk
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2005
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 15, 2005
CompletedFirst Posted
Study publicly available on registry
December 16, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedMay 28, 2010
December 1, 2005
December 15, 2005
May 27, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Fatty acid composition of PMBC - before and after 2 mo of interventions and after 2 mo of follow-up
Ex vivo cytokine production (e.g. IL-6, TNF-α, IL-10, and interferon-γ) in whole blood and PBMC cultures after 24 h of stimulation - before and after interventions and after follow up
Plasma CRP, IL-6 & fibrinogen - before, after and follow-up
Plasma lipid profile: TAG, cholesterol, LDL & HDL - before, after and follow-up
Blood pressure - before, after and follow-up
Secondary Outcomes (11)
Anthropometric measures - before, after & follow-up
Ex vivo cytokine production in isolated monocytes - after intervention only
Endothelial function (PWV and/or arterial compliance) - before & after
Superoxide production in full blood samples - before & after
Plasma insulin/glucose - before, after and follow-up
- +6 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Healthy (no chronic diseases and no regular medications)
- BMI \>18.5 and \<27.5 kg/m2
- Daily use of fats and home cooking \>5 d/wk
- Heavy exercise \<7 h/wk
- Not daily smokers (\<5 cigarets/wk)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Copenhagenlead
- Danish Research Agencycollaborator
- Hjerteforeningencollaborator
- Technical University of Denmarkcollaborator
Study Sites (1)
Department of Human Nutrition
Frederiksberg, DK-1958, Denmark
Related Publications (4)
Damsgaard CT, Lauritzen L, Calder PC, Kjaer TR, Frokiaer H. Reduced ex vivo interleukin-6 production by dietary fish oil is not modified by linoleic acid intake in healthy men. J Nutr. 2009 Jul;139(7):1410-4. doi: 10.3945/jn.108.102269. Epub 2009 Jun 3.
PMID: 19494025RESULTDamsgaard CT, Lauritzen L, Calder PC, Kjaer TM, Frokiaer H. Whole-blood culture is a valid low-cost method to measure monocytic cytokines - a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J Immunol Methods. 2009 Jan 30;340(2):95-101. doi: 10.1016/j.jim.2008.10.005. Epub 2008 Nov 8.
PMID: 19000693RESULTDamsgaard CT, Frokiaer H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr. 2008 Jun;138(6):1061-6. doi: 10.1093/jn/138.6.1061.
PMID: 18492834RESULTBartelt S, Timm M, Damsgaard CT, Hansen EW, Hansen HS, Lauritzen L. The effect of dietary fish oil-supplementation to healthy young men on oxidative burst measured by whole blood chemiluminescence. Br J Nutr. 2008 Jun;99(6):1230-8. doi: 10.1017/S0007114507853451. Epub 2008 Jan 17.
PMID: 18199388RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lotte Lauritzen, Ph.D
Department of Human Nutrition, Royal Veterinary and Agricultural University, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 15, 2005
First Posted
December 16, 2005
Study Start
September 1, 2005
Study Completion
April 1, 2006
Last Updated
May 28, 2010
Record last verified: 2005-12